Matthew H. Kulke

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.3K citations

Medicine, Oncology, Surgery +12

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors

Matthew H. Kulke, Heinz‐Josef Lenz, Neal J. Meropol et al. · Journal of Clinical Oncology · 2008 · 620 citations · Full text

Medicine, Oncology, Pharmacology +16

Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors

Pamela L. Kunz, Diane Reidy‐Lagunes, Lowell Anthony et al. · Pancreas · 2013 · 586 citations · Full text

Medicine, Endocrinology, Oncology +13